| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
|---|---|---|---|
| Report Filing | 2025-11-12 | 2024-12-31 | 2023-12-31 |
| Revenue | 41.63 | 31.62 | 19.27 |
| Cost of Revenue | 9.71 | 7.28 | 4 |
| Gross Profit | 31.91 | 24.34 | 15.27 |
| Operating Expenses | 53.25 | 38.99 | 26.13 |
| Research & Development | 5.68 | 4.49 | 3.02 |
| Selling, General and Administrative | 47.56 | 34.51 | 23.11 |
| Other Operating Expenses | 0 | 0 | 0 |
| Operating Income | -21.33 | -14.65 | -10.86 |
| Net Non-Operating Interest | -1.05 | -1.32 | -0.761 |
| Interest Income | 0 | 0 | 0 |
| Interest Expense | 1.05 | 1.32 | 0.761 |
| Equity & Other Income/(Expense) | -13.99 | 0.35 | -1.03 |
| Income Before Tax | -36.38 | -15.62 | -12.65 |
| Income Tax Expense | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 |
| Net Income | -36.38 | -15.62 | -12.65 |
| Depreciation and Amortization | 2.23 | 2.2 | 1.64 |
| EBITDA | -19.11 | -12.46 | -9.22 |
| Earnings Per Share (EPS) | -1.43 | -0.77 | -0.63 |
| Diluted Earnings Per Share | -1.43 | -0.77 | -0.63 |
| Weighted Average Shares Outstanding | 136 | 20.23 | 20.23 |
| Diluted Weighted Average Shares Outstanding | 136 | 20.23 | 20.23 |
